Division of Infectious Diseases

Faculty & Research

Faculty & Research 

Our investigators advance the study of infectious diseases and the pathogens that cause them through hands-on field work supporting basic science research as well as investigator-initiated and industry-sponsored clinical trials. more info 


Infectious Diseases Fellowship Program

Education & Training 

Fellowship Overview   

ID Newsletter 

Introductory Lectures for Fellows  

Transplant Bootcamp Series 2021   

2021 Montefiore Einstein ID Fellowship Orientation Slides  

Educational Videos 


Patient Care & Clinical Services

Patient Care & Clinical Services 

Doctor Visits  

COVID-19: What you need to know from Montefiore 

Schedule an appointment, refer a patient, Montefiore Einstein ID treatment centers. more info 




Policies, schedules, antibiotic booklet, and useful links. more info 

News & Media

ID Team Publications


Jacqueline Achkar, M.D.Using Proteins to Predict Active TB 

Jacqueline Achkar, M.D., Biomarkers indicating the occurrence of active and contagious tuberculosis (TB) before someone develops symptoms would especially help people living with HIV (PLHIV).

ID Team on COVID-19 (Publications)


Barry S. Zingman, M.D.New COVID-19 Vaccine Unit Opens at Montefiore and Albert Einstein College of Medicine 

Barry S. Zingman, M.D., Montefiore’s goal is to ensure more than half of all trial participants are adults most affected by COVID-19, with a focus on people older than 65. Across the country, older individuals and communities of color have been disproportionately impacted by the pandemic.


Liise-anne Pirofksi, M.D.NY doctor spearheading blood trial to help treat coronavirus patients 

Liise-anne Pirofski, M.D., discusses the use of plasma from people who have recovered from COVID-19 to potentially prevent and treat the disease. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore.

Additional coverage includes: The Lancet, CNN, USA Today, Nature, The Atlantic, Wall Street Journal (subscription required), Associated Press, NPR, LA Times, NBC News, CBS News 


Joshua Nosanchuk, M.D.Back to Medical School During COVID-19 

Joshua Nosanchuk, M.D., describes how, during the COVID-19 pandemic, Einstein medical students are contributing their ideas on how to accelerate courses—all while ensuring alignment with Einstein's mission and accreditation requirements. Dr. Nosanchuk is senior associate dean for medical education and professor of medicine and of microbiology & immunology. Read More.

Marla Keller, M.D.A Blood Test May Show Which COVID-19 Patients Steroids Will Help—Or Harm
Marla Keller, M.D., Will Southern, M.D., M.S., and Shitij Arora, M.D., are co-authors on a study that finds a blood test can help physicians determine which hospitalized patients with COVID-19 can benefit from steroids. Dr. Keller is vice chair of research in the department of medicine; Dr. Southern is chief of hospital medicine; and Dr. Arora is associate professor of medicine and a hospitalist at Montefiore. 

Additional coverage includes USA Today, LoHud, Fox News, U.S. News & World Report (via HealthDay), Daily Mail, LabPulse

Liise-anne Pirofksi, M.D.Combating the COVID-19 Pandemic with Antibodies and a Patient Database
Along with many other Einstein and Montefiore scientists and physicians, infectious disease expert Liise-anne Pirofski, M.D., is working overtime to confront COVID-19, the disease caused by the new coronavirus. 

How blood from coronavirus survivors might save lives 

Dr. Liise-anne Pirofski Speaks to CNN About New COVID-19 Clinical Trial 


JCI article on SARS-Cov-2 viral and antibody kinetics argues that convalescent plasma (CP) therapy functions differently early and late in COVID-19. 

JCI article Kinetics of Viral Load and Antibody Response in Relation to COVID-19 Severity.

Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework 

LA Times: Clinical Trial testing the healing powers of blood from COVID-19 Survivors 


Barry S. ZingmanTrial for Potential Coronavirus Treatment is Underway at Montefiore and Einstein 
Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.


Priya NoriAntibiotic treatment for COVID-19 complications could fuel resistant bacteria 
“We tend not to hold back on antibiotics in these patients,” Nori says, especially when that decision could mean life or death. “Is that a bad thing right now? I have trouble saying that it is.” 


Vagish HemmigeRachel BartashCovid-19 and Kidney Transplantation 
To the Editor: Kidney-transplant recipients appear to be at particularly high risk for critical Covid-19 illness due to chronic immunosuppression and coexisting conditions.   


news & multimedia archive 

Division Chief

Liise-anne Pirofski, M.D.

Liise-anne Pirofski, M.D. (Bio)
Professor, Department of Medicine (Infectious Diseases)
Professor, Department of Microbiology & Immunology
Chief, Division of Infectious Diseases , Department of Medicine
Selma and Dr. Jacques Mitrani Chair in Biomedical Research



Case of the Month

March - 2022 

An 8 year-old boy with a history of prematurity, short bowel syndrome secondary to gastroschisis and necrotizing enterocolitis presented to the Emergency Room with headache and 101°F fever....  more info      

March 2022a March 2022b      

Previous Cases 


Conferences & Seminars

No Grand Rounds at this time

Click here to log in